rotagrreste 12.5mg/50ml i.v. infusion 50 ml
روتاجريست 12.5مجم/50مل محلول وريدي 50 مل
tirofibanThe published official price. Pharmacies may differ slightly.
- Strength
- 12.5mg/50ml
- Form
- solution
- Manufacturer
- alexandria > rotabiogen for pharmaceutical invest.
- Route
- injection
The medical information below is guidance and may be incomplete or wrong. Do not change your medicine or dose based on it — ask a pharmacist or doctor.
Uses
Used to reduce thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome, often alongside other antithrombotic therapies.
Do not use if
Active internal bleeding, history of severe bleeding disorders, prior tirofiban-induced thrombocytopenia, or hypersensitivity.
Side effects
Bleeding is the most common adverse effect. Thrombocytopenia and hypersensitivity reactions may also occur.
Warnings
May cause serious bleeding. Monitor platelet count and discontinue if severe thrombocytopenia develops.
How it works
Reversible glycoprotein IIb/IIIa receptor antagonist that inhibits platelet aggregation.
Storage
Store according to product labeling at controlled room temperature.